Connective Tissue Genes: EDS, HSD, and the Genetic Landscape

Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorder (HSD) are connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. While the genetic basis of most classical EDS subtypes is well-established (COL5A1/COL5A2 for classical EDS, COL3A1 for vascular EDS), the genetics of hypermobile EDS (hEDS) — the most common subtype — remain incompletely understood. This article reviews the current state of connective tissue genetics and what it means for patients.

Classical EDS Subtypes: Known Genetics

For most EDS subtypes, the causative gene is known and genetic testing is diagnostic:

For these subtypes, a positive genetic test confirms the diagnosis. However, these subtypes are rare — together they account for a small minority of EDS diagnoses.

Hypermobile EDS: The Genetic Mystery

Hypermobile EDS (hEDS) is by far the most common EDS subtype, accounting for approximately 80–90% of all EDS diagnoses. Despite its prevalence, no causative gene has been identified for hEDS, and it remains the only EDS subtype without a confirmed genetic basis. This is not because hEDS is not genetic — it clearly runs in families with an autosomal dominant pattern — but because it is likely genetically heterogeneous, meaning multiple different genetic variants can produce the same clinical phenotype.

Several candidate genes have been proposed for hEDS:

TNXB (tenascin-X). Haploinsufficiency of tenascin-X causes a connective tissue disorder that closely resembles hEDS. Tenascin-X is an extracellular matrix glycoprotein that regulates collagen fibril assembly. TNXB variants are found in a subset of hEDS patients and may account for 5–10% of cases.

COL12A1 (type XII collagen). Type XII collagen interacts with type I collagen and regulates collagen fibril organization. Variants in COL12A1 have been identified in some hEDS families and in patients with a phenotype overlapping hEDS and classical EDS.

AEBP1. A 2019 study identified AEBP1 variants in a subset of patients with a connective tissue disorder resembling hEDS. AEBP1 encodes a transcription factor involved in connective tissue homeostasis.

FBN1 and FBN2 (fibrillin-1 and fibrillin-2). Fibrillin variants cause Marfan syndrome and congenital contractural arachnodactyly, but milder variants may contribute to connective tissue hypermobility without meeting criteria for these diagnoses.

The Autonomic Connection: Connective Tissue and POTS

The high prevalence of POTS in hEDS/HSD patients (estimated at 30–50%) is not coincidental. Several mechanisms link connective tissue abnormalities to autonomic dysfunction:

Venous pooling. Lax connective tissue in blood vessel walls reduces venous tone, leading to excessive blood pooling in the lower extremities on standing — a direct driver of orthostatic tachycardia.

Mast cell proximity. Mast cells are embedded in connective tissue throughout the body. Abnormal connective tissue matrix may alter mast cell signaling and contribute to the high prevalence of MCAS in hEDS patients.

Proprioceptive dysfunction. Connective tissue abnormalities affect joint proprioception — the sense of joint position. Impaired proprioception may disrupt the autonomic reflexes that normally compensate for postural changes.

RCCX module. A cluster of genes on chromosome 6 — the RCCX module — includes CYP21A2 (21-hydroxylase), C4A/C4B (complement components), and TNXB. Copy number variations in this region can simultaneously affect connective tissue integrity, immune function, and steroid hormone metabolism, potentially explaining the hEDS-MCAS-POTS triad.

Genetic Testing for Connective Tissue Disorders

For patients with suspected EDS, genetic testing is most useful for ruling out specific subtypes:

• Vascular EDS (COL3A1) — should be tested in patients with family history of arterial rupture, bowel perforation, or uterine rupture
• Classical EDS (COL5A1/COL5A2) — testing is available and may be positive in patients with significant skin fragility
• Kyphoscoliotic EDS (PLOD1/FKBP14) — testing indicated in patients with progressive scoliosis and muscle hypotonia

For hEDS, genetic testing is currently not diagnostic — no single gene test can confirm or rule out hEDS. Research panels testing multiple candidate genes are available through some academic centers and may provide useful information, but results should be interpreted cautiously given the incomplete understanding of hEDS genetics.

Key Takeaways

The genetics of connective tissue disorders in the dysautonomia community are complex and incompletely understood. For most hEDS patients, genetic testing will not provide a definitive answer — but it can rule out more serious subtypes and may identify variants in candidate genes that inform management. The connection between connective tissue genes and autonomic dysfunction is real and mechanistically plausible, and ongoing research is gradually clarifying the genetic architecture of hEDS.

This article is for informational purposes only and does not constitute medical advice.